arrow
C

Caroline M. Apovian

Harvard Medical School
H指数:69
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Accuracy, potential harm, weight stigma, and commercial influence in short-form social media content on incretin-based therapies for obesity

关于瘦素基治疗肥胖的短视频社交媒体内容中的准确性、潜在危害、体重歧视及商业影响

2026-10-020
OAAI
Precision Prevention, Diagnostics, and Treatment of Obesity: Pipedream or Reality?

肥胖的精准预防、诊断与治疗:是空中楼阁还是现实?

OBESITY
IF4.7
2025-09-010
OA
Novel strategies for medical management of obesity: mechanisms, clinical implications, and societal impacts—a report from the 25th Annual Harvard Nutrition Obesity Symposium

肥胖医疗管理的新策略:机制、临床意义和社会影响——哈佛营养与肥胖年度研讨会第25届会议报告

2025-06-210
PREAI
Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society

支持肥胖GLP-1疗法营养优先事项:美国生活方式医学会、美国营养学会、肥胖医学协会和肥胖学会联合建议书

2025-05-300
OA
Nutritional priorities to support GLP-1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society

支持肥胖GLP-1疗法的营养优先事项:美国生活方式医学学会、美国营养学会、肥胖医学协会和肥胖学会联合建议

Obesity
IF4.7
2025-05-300
OA
Response to the Letter to the Editor by Athinarayanan
OBESITY
IF4.7
2024-12-150
OAAI
Response to the Letter to the Editor by Bett et al.
OBESITY
IF4.7
2024-10-030
OAAI
Nutritional considerations with antiobesity medications

抗肥胖药物的营养考虑

OBESITY
IF4.7
2024-06-1014
OAAI